It has been demonstrated that obesity up-regulates hepatic expressions of MSRB1, SELENON, -P, and -W, as well as GPX4 in diabetic patients by 33–50%, as compared to non-obese examinees [227]. Here, MSRB1 is linked to obesity disorder.